Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis
- 30 November 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (5) , 839-846
- https://doi.org/10.1067/mai.2001.118796
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitisJournal of the American Academy of Dermatology, 2001
- T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisJournal of Clinical Investigation, 2000
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceNew England Journal of Medicine, 1999
- Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroidal therapyJournal of Allergy and Clinical Immunology, 1999
- Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact HypersensitivityThe Journal of Experimental Medicine, 1999
- Comparison of Two Formulations of Cyclosporin A in the Treatment of Severe Atopic DermatitisDermatology, 1999
- FK506 in the treatment of inflammatory skin disease: promises and perspectivesImmunology Today, 1996
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Time-dependent inhibition of growth of human keratinocytes and fibroblasts by cyclosporin A: effect on keratinocytes at therapeutic blood levelsBritish Journal of Dermatology, 1990
- Atopic dermatitisJournal of the American Academy of Dermatology, 1982